Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer

Conditions:   Merkel Cell Carcinoma;   Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8 Interventions:   Biological: Ipilimumab;   Biological: Nivolumab;   Radiation: Radiation Therapy Sponsors:   Hiral Shah;   National Cancer Institute (NCI) Recruiting

Source: ClinicalTrials.gov - January 10, 2019 Category: Research Source Type: clinical trials